1299 related articles for article (PubMed ID: 6810694)
1. Serum apolipoprotein A-I levels: relationship to lipoprotein lipid levels and selected demographic variables.
Phillips NR; Havel RJ; Kane JP
Am J Epidemiol; 1982 Aug; 116(2):302-13. PubMed ID: 6810694
[TBL] [Abstract][Full Text] [Related]
2. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
[TBL] [Abstract][Full Text] [Related]
3. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
[TBL] [Abstract][Full Text] [Related]
5. Associations of oral contraceptive use with serum lipids and lipoproteins in young women: the Bogalusa Heart Study.
Greenlund KJ; Webber LS; Srinivasan S; Wattigney W; Johnson C; Berenson GS
Ann Epidemiol; 1997 Nov; 7(8):561-7. PubMed ID: 9408552
[TBL] [Abstract][Full Text] [Related]
6. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.
Oyelola OO
Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. II. Serum lipoproteins and apolipoproteins.
Ahrén T; Lithell H; Victor A; Vessby B; Johansson ED
Contraception; 1981 Oct; 24(4):451-68. PubMed ID: 6797786
[TBL] [Abstract][Full Text] [Related]
8. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
Lipson A; Stoy DB; LaRosa JC; Muesing RA; Cleary PA; Miller VT; Gilbert PR; Stadel B
Contraception; 1986 Aug; 34(2):121-34. PubMed ID: 3096633
[TBL] [Abstract][Full Text] [Related]
9. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
10. The interaction of alcohol consumption and oral contraceptive use on lipids and lipoproteins.
Kruszon-Moran D; Burkman RT; Kimball AW; Bachorik PS; Gold EB
Contraception; 1988 Jan; 37(1):39-51. PubMed ID: 3365983
[TBL] [Abstract][Full Text] [Related]
11. Cyclic fluctuations in human serum lipid and apolipoprotein levels during the normal menstrual cycle: comparison with changes occurring during oral contraceptive therapy.
Lussier-Cacan S; Xhignesse M; Desmarais JL; Davignon J; Kafrissen ME; Chapdelaine A
Metabolism; 1991 Aug; 40(8):849-54. PubMed ID: 1907348
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E polymorphism in men and women from a Spanish population: allele frequencies and influence on plasma lipids and apolipoproteins.
Gómez-Coronado D; Alvarez JJ; Entrala A; Olmos JM; Herrera E; Lasunción MA
Atherosclerosis; 1999 Nov; 147(1):167-76. PubMed ID: 10525138
[TBL] [Abstract][Full Text] [Related]
13. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
[TBL] [Abstract][Full Text] [Related]
14. Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases.
Cai HJ; Li ZX; Yang SM
Atherosclerosis; 1982 Jun; 43(2-3):197-207. PubMed ID: 7115460
[TBL] [Abstract][Full Text] [Related]
15. Adverse influences of alcohol, tobacco, and oral contraceptive use on cardiovascular risk factors during transition to adulthood.
Croft JB; Freedman DS; Cresanta JL; Srinivasan SR; Burke GL; Hunter SM; Webber LS; Smoak CG; Berenson GS
Am J Epidemiol; 1987 Aug; 126(2):202-13. PubMed ID: 3605049
[TBL] [Abstract][Full Text] [Related]
16. [Value of the analysis of lipoproteins after myocardial infarction].
Dewailly P; Mellin D; Moulin S; Rouget JP; Sezille G; Jaillard J
Presse Med; 1983 Jul 9-16; 12(29):1807-10. PubMed ID: 6224195
[TBL] [Abstract][Full Text] [Related]
17. Black-white differences in plasma levels of apolipoproteins: the Evans County Heart Study.
Heiss G; Schonfeld G; Johnson JL; Heyden S; Hames CG; Tyroler HA
Am Heart J; 1984 Sep; 108(3 Pt 2):807-14. PubMed ID: 6433686
[TBL] [Abstract][Full Text] [Related]
18. Plasma lipoprotein changes during abstinence in chronic alcoholics.
Weidman SW; Beard JD; Sabesin SM
Atherosclerosis; 1984 Aug; 52(2):151-66. PubMed ID: 6433939
[TBL] [Abstract][Full Text] [Related]
19. Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.
Walsh BW; Sacks FM
J Clin Invest; 1993 May; 91(5):2126-32. PubMed ID: 8486779
[TBL] [Abstract][Full Text] [Related]
20. Metabolic effects of a biphasic oral contraceptive preparation containing ethinyloestradiol and desogestrel on serum lipoproteins and apolipoproteins.
Voorhoof L; Rosseneu M; Caster H; De Keersgieter W
J Endocrinol; 1986 Oct; 111(1):191-6. PubMed ID: 2946795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]